The Ibogaine Conversation
A multi-part series, explores everything from iboga’s traditional Bwiti use in Gabon, Africa, to its ability to treat opioid addiction and withdrawal, to its safety and very real risks.
A multi-part series, explores everything from iboga’s traditional Bwiti use in Gabon, Africa, to its ability to treat opioid addiction and withdrawal, to its safety and very real risks.
The Ibogaine Conversation Part 1 | This series explores the unique challenges ibogaine presents in how we approach plant medicine, harm reduction, and treatment for addiction, through the lens of ibogaine researchers, providers, patients, and advocates from around the world.
The Ibogaine Conversation Part 2 | Our first stop is in Gabon, Africa, where consumption of the iboga root bark is intimately tied to the ancient spiritual discipline known as Bwiti.
The Ibogaine Conversation Part 3 | What is the authentic Bwiti tradition? The answer I got was that this idea of authenticity is an odd idea. It’s a very Western idea. Bwiti considers itself as a culture that’s changing.
The Ibogaine Conversation Part 4 | The Western world cannot receive the benefits of iboga if they don’t try to understand and assimilate the traditional approach.
The Ibogaine Conversation Part 5 | Thomas Kingsley Brown, PhD, studied the long-term outcomes of people who received ibogaine for the treatment of opioid addiction. We talked about the results.
The Ibogaine Conversation Part 6 | My experience with heroin went from age 14 up to age 30, and taking ibogaine was as close to a miracle as I have ever experienced in my life.
The Ibogaine Conversation Part 7 | “Prescription is not about accessibility, by definition it’s about restriction. Unless we start to use psychedelics as a way to tear apart these structures and build new ones in their place, then I think it’s all a revolving door.”
The Ibogaine Conversation Part 8 | This is not a do-it-at-home type thing.
The Ibogaine Conversation Part 9 | Using ibogaine can be fatal if proper safety precautions aren’t taken.
The Ibogaine Conversation Part 10 | Unlike other psychedelic drugs, ibogaine is known to be potentially cardiotoxic. There are a number of fatalities associated with its use, and anyone considering working with it should be aware of the risks.
The Ibogaine Conversation Conclusion | The goal of this conversation was to provide a platform for a diverse range of perspectives on a single topic. Not everyone agrees, and that’s the point.
Psymposia is a research and media 501(c)(3) nonprofit that offers critical perspectives on drugs, politics, and culture. We rely on audience support to keep our work independent and focused on the public interest. You can sustain Psymposia by becoming a member, which includes exclusive content and perks.